breast cancer, hormones - Yahoo Search Results

Ads
related to: breast cancer, hormones
HR+, HER2- Breast Cancer Info - Official HCP Website

www.advanced-breast-cancer.com
Your Premenopausal mBC Patients Could Qualify For Financial Help. See A Treatment Option. View An Option For 1L Premenopausal Metastatic Breast Cancer At The Official HCP Website.
Safety Information · Co-Pay Card · Efficacy Information · Official Video Library
Types: Postmenopausal mBC, Premenopausal mBC, mBC Combination Therapy
Overall Survival Results
See Updated Overall Survival Data

For This Treatment Option

Dosing & Administration
Read More About Dosing

And How To Prescribe

Patient Support
View The The Service Request Form

To Gain Access To Support Programs

Safety Profile
View The Full Safety Profile And

See Side Effects For This Option

Financial Resources
Learn About The Available Access

Programs For Your Patients

Official Video Library
See A Medical Expert Discuss

Overall Survival Data For mBC
MBC Treatment Option - Patients & Care Partner Site

metastatic-breast-cancer-drug.com
See If A Treatment For Metastatic Breast Cancer Is An Option For You Or A Loved One. Visit Patient Site To Learn More.
MBC Treatment Option · Patients & Care Partners · Register For Updates · Support Resources For You
Understand Your Diagnosis
Get MBC Treatment Info
Safety Info & Study Data
MBC Treatment Option

Search results

- Most young women treated for breast cancer can have children, study shows
  Medical Xpress· 3 hours ago
  New research by Dana-Farber Cancer Institute investigators has encouraging news for young women who...
- ... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
  WJTV Jackson· 3 hours ago
  The data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical...
- ASCO24: An early look at cancer drug study results
  BioPharma Dive via Yahoo Finance· 6 hours ago
  Its first chance to break into the field could be JNJ-6420, a drug that executives already billed as a potential future blockbuster. J&J aims to show the...
- Is Vaginal Estrogen Safe in Breast Cancer Survivors?
  Medscape· 19 hours ago
  Vaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently...
- Breast cancer signs for men
  Rolling Out· 5 days ago
  Breast cancer is generally considered a women's health concern, but men can also develop this form of cancer. While less common, male breast cancer is
- Premature menopause can come with 'serious' health risks, study says. A Canadian doctor says you...
  Yahoo Canada Style· 4 hours ago
  In Canada, cardiovascular disease is the no,. 1 killer amongst women: "A lot of women worry about ...
- Former Dana-Farber patient leads startup aimed at cancer survivors - Boston Business Journal
  The Business Journals· 10 hours ago
  Motivated by her own experience as a breast cancer survivor, a Massachusetts CEO is launching a tech-enabled healthcare service for those coming out of ...
- Preserving breast tissue outside of body will aid cancer research – study
  PA Media: Science via Yahoo News· 4 days ago
  “This is a real game-changer for breast cancer research in many ways. “We can better test drugs for...
- Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
  Medscape· 4 days ago
  Patients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
- Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual...
  FOX21 Colorado Springs· 3 hours ago
  Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor), Retevmo® (selpercatinib; a rearranged during transfection [RET] inhibitor ...